Although the broader healthcare sector has witnessed significant turbulence throughout this year, some notable players have been making positive...
Straight up, I’m not a big fan of trading securities in the pharmaceutical and biotechnology spaces — essentially, anything can happen (and...
Generally speaking, I’m not a big fan of discussing biopharmaceutical firms such as Gilead Sciences (NASDAQ:GILD). While the sector is intriguing...
Congresswoman Marjorie Taylor Greene has made a name for herself in the stock market by having a knack for timing transactions to major events. Last...
There are several different ways to evaluate penny stocks using fundamental and technical analysis... One that has worked very well in 2020 is...
The Dow Jones now wrestles between rising coronavirus cases in certain areas and a dovish Fed policy.
The index has gained a few new...
The Dow Jones lost more than 200 points in the first five minutes today.
Markets could finally be reflecting the economic devastation of...
Investors got another vote of confidence today and bid stocks higher after Dr. Anthony Fauci expressed optimism about a potential coronavirus...
Georgia, South Carolina, and Florida have announced that they are loosening quarantine restrictions; at least 13 more states have...
The Dow Jones is up today as states discuss opening their economies over the coming weeks.
Despite the efforts, COVID-19 will be...
The Dow Jones is flat this morning as the coronavirus sparks fear of economic collapse.
Congress just unveiled a new emergency spending...
This morning, United States weekly jobless claims came in at 4.4 million.
Just over 26 million Americans have now applied for...
Today was one for the history books.
The spot oil price for May futures contracts closed at negative $37.63.
Essentially, that...
This was another unprecedented week for the financial markets.
We saw an additional 5.2 Americans lose their jobs and file for...
The Dow Jones popped this morning on news that a drug from Gilead Sciences (NASDAQ: GILD) showed some effectiveness in treating patients with...
Last week gave hope that stock markets had found a bottom, with a three-day rally that brought the Dow up over 20% from Monday's close through the...
With recession indicators flashing, investors are flocking to 10-year bonds that have the annual upside of just 1.5%.
But there are still...
It was the very first stock that I recommended on the very first day we published Private Briefing nearly eight years ago...
I've...
Biotech companies are known for their potential to break out when a new drug comes to market, and today we're giving you two of the best biotech...
At the end of 2018, the Federal Reserve told the market the water was warm, come in for a swim.
The market was happy to oblige. In fact,...